Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-06-01 Sale |
2021-06-03 4:07 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
9,562 | $14.62 | $139,797 | 147,251 (Direct) |
View |
| 2021-05-11 Sale |
2021-05-13 4:13 pm |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D |
3,125 | $19.3 | $60,312 | 31,707 (Direct) |
View |
| 2021-05-11 Sale |
2021-05-13 4:11 pm |
Travere Therapeutics Inc. | TVTX | Rosenberg Noah L. Chief Medical Officer |
750 | $19.3 | $14,475 | 45,594 (Direct) |
View |
| 2021-05-11 Sale |
2021-05-13 4:09 pm |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary |
3,250 | $19.3 | $62,725 | 34,455 (Direct) |
View |
| 2021-05-11 Sale |
2021-05-13 4:07 pm |
Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer |
4,000 | $19.3 | $77,200 | 28,223 (Direct) |
View |
| 2021-05-11 Sale |
2021-05-13 4:05 pm |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
2,146 | $19.58 | $42,023 | 186,794 (Direct) |
View |
| 2021-04-16 Sale |
2021-04-20 4:05 pm |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
10,000 | $26.23 | $262,300 | 328,940 (Direct) |
View |
| 2021-03-17 Sale |
2021-03-19 4:05 pm |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
17,727 | $27.44 | $486,456 | 338,940 (Direct) |
View |
| 2021-02-17 Sale |
2021-02-18 6:26 pm |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D |
2,500 | $28.01 | $70,025 | 34,832 (Direct) |
View |
| 2021-02-05 Sale |
2021-02-09 4:32 pm |
Travere Therapeutics Inc. | TVTX | Rosenberg Noah L. Chief Medical Officer |
2,250 | $31.5 | $70,864 | 46,344 (Direct) |
View |
| 2021-02-05 Sale |
2021-02-09 4:31 pm |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
2,250 | $31.5 | $70,864 | 59,344 (Direct) |
View |
| 2021-02-05 Sale |
2021-02-09 4:30 pm |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D |
4,500 | $31.5 | $141,728 | 37,332 (Direct) |
View |
| 2021-02-05 Sale |
2021-02-09 4:30 pm |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary |
4,500 | $31.5 | $141,728 | 37,705 (Direct) |
View |
| 2021-02-05 Sale |
2021-02-09 4:29 pm |
Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer |
4,500 | $31.5 | $141,728 | 32,223 (Direct) |
View |
| 2021-02-05 Sale |
2021-02-09 4:28 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
9,626 | $31.5 | $303,171 | 156,813 (Direct) |
View |
| 2021-02-02 Sale |
2021-02-03 9:33 pm |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
1,126 | $29.83 | $33,589 | 57,094 (Direct) |
View |
| 2021-02-03 Sale |
2021-02-03 9:33 pm |
Travere Therapeutics Inc. | TVTX | Rosenberg Noah L. Chief Medical Officer |
1,813 | $28.91 | $52,414 | 44,094 (Direct) |
View |
| 2021-02-03 Sale |
2021-02-03 9:32 pm |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D |
3,625 | $28.91 | $104,799 | 37,332 (Direct) |
View |
| 2021-02-03 Sale |
2021-02-03 9:31 pm |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary |
3,175 | $28.91 | $91,789 | 37,705 (Direct) |
View |
| 2021-02-03 Sale |
2021-02-03 9:30 pm |
Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer |
3,625 | $28.91 | $104,799 | 32,223 (Direct) |
View |
| 2021-02-03 Sale |
2021-02-03 9:29 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
2,406 | $28.91 | $69,557 | 148,939 (Direct) |
View |
| 2021-02-02 Sale |
2021-02-02 9:31 pm |
Travere Therapeutics Inc. | TVTX | Rosenberg Noah L. Chief Medical Officer |
1,813 | $30.75 | $55,750 | 45,907 (Direct) |
View |
| 2021-02-02 Sale |
2021-02-02 9:23 pm |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D |
3,625 | $30.75 | $111,469 | 43,457 (Direct) |
View |
| 2021-02-02 Sale |
2021-02-02 9:21 pm |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary |
3,175 | $30.75 | $97,631 | 40,880 (Direct) |
View |
| 2021-02-02 Sale |
2021-02-02 9:20 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
8,734 | $29.91 | $261,267 | 151,345 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-05-14 Option Award |
2021-05-18 9:30 pm |
2022-05-14 2031-05-13 |
Travere Therapeutics Inc. | TVTX | COUGHLIN TIMOTHY Director |
12,000 | $0 | 44,000 (Direct) |
View |
| 2021-05-14 Option Award |
2021-05-18 9:26 pm |
2022-05-14 2031-05-13 |
Travere Therapeutics Inc. | TVTX | Bruhn Suzanne Louise Director |
12,000 | $0 | 17,250 (Direct) |
View |
| 2021-05-14 Option Award |
2021-05-18 9:25 pm |
2022-05-14 2031-05-13 |
Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director |
12,000 | $0 | 26,000 (Direct) |
View |
| 2021-05-14 Option Award |
2021-05-18 9:22 pm |
2022-05-14 2031-05-13 |
Travere Therapeutics Inc. | TVTX | LYONS GARY A Director |
12,000 | $0 | 46,000 (Direct) |
View |
| 2021-05-14 Option Award |
2021-05-18 9:21 pm |
2022-05-14 2031-05-13 |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
12,000 | $0 | 198,794 (Direct) |
View |
| 2021-05-14 Option Award |
2021-05-18 9:19 pm |
2022-05-14 2031-05-13 |
Travere Therapeutics Inc. | TVTX | Meckler Jeffrey A Director |
12,000 | $0 | 76,000 (Direct) |
View |
| 2021-05-14 Option Award |
2021-05-18 9:17 pm |
2022-05-14 2031-05-13 |
Travere Therapeutics Inc. | TVTX | Orwin John A Director |
12,000 | $0 | 23,875 (Direct) |
View |
| 2021-05-14 Option Award |
2021-05-18 9:13 pm |
2022-05-14 2031-05-13 |
Travere Therapeutics Inc. | TVTX | Poole Sandra Director |
12,000 | $0 | 18,500 (Direct) |
View |
| 2021-05-14 Option Award |
2021-05-18 9:11 pm |
2022-05-14 2031-05-13 |
Travere Therapeutics Inc. | TVTX | Squarer Ron Director |
12,000 | $0 | 23,875 (Direct) |
View |
| 2021-04-16 Exercise |
2021-04-20 4:05 pm |
N/A 2026-05-18 |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
10,000 | $0 | 328,940 (Direct) |
View |
| 2021-04-16 Exercise |
2021-04-20 4:05 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
10,000 | $16.23 | 328,940 (Direct) |
View |
| 2021-03-17 Exercise |
2021-03-19 4:05 pm |
N/A 2026-05-18 |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
10,000 | $0 | 338,940 (Direct) |
View |
| 2021-03-17 Exercise |
2021-03-19 4:05 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
10,000 | $16.23 | 338,940 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 4:49 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Rosenberg Noah L. Chief Medical Officer |
4,500 | $0 | 48,594 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 4:49 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D |
4,500 | $0 | 41,832 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 4:48 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
4,500 | $0 | 61,594 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 4:47 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary |
4,500 | $0 | 42,205 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 4:46 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer |
4,500 | $0 | 36,723 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 4:46 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
17,500 | $0 | 166,439 (Direct) |
View |
| 2021-01-31 Option Award |
2021-02-02 9:31 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Rosenberg Noah L. Chief Medical Officer |
5,000 | $0 | 45,907 (Direct) |
View |
| 2021-01-31 Option Award |
2021-02-02 9:23 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D |
5,000 | $0 | 43,457 (Direct) |
View |
| 2021-01-31 Option Award |
2021-02-02 9:21 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary |
5,000 | $0 | 40,880 (Direct) |
View |
| 2021-01-31 Option Award |
2021-02-02 9:20 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
15,000 | $0 | 151,345 (Direct) |
View |